Jagsonpal Pharmaceuticals

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue61.8858.0162.1560.1049.77
Expenses52.0250.6952.0650.1444.50
EBITDA10.388.0010.6310.645.92
EBIT10.057.5210.2410.185.51
Profit Before Tax9.877.3210.099.965.28
Net Profit7.795.607.487.473.96
Financial Ratios
Operating Profit Margin17.26%14.43%17.67%18.40%12.53%
Net Profit Margin12.95%10.10%12.44%12.92%8.38%
Earning Per Share (Diluted)2.972.142.852.841.47
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ